一种治疗顽固性高血压的新方法经导管肾神经消融_蒋雄京.ppt

上传人:本田雅阁 文档编号:2780598 上传时间:2019-05-15 格式:PPT 页数:23 大小:3.34MB
返回 下载 相关 举报
一种治疗顽固性高血压的新方法经导管肾神经消融_蒋雄京.ppt_第1页
第1页 / 共23页
一种治疗顽固性高血压的新方法经导管肾神经消融_蒋雄京.ppt_第2页
第2页 / 共23页
一种治疗顽固性高血压的新方法经导管肾神经消融_蒋雄京.ppt_第3页
第3页 / 共23页
一种治疗顽固性高血压的新方法经导管肾神经消融_蒋雄京.ppt_第4页
第4页 / 共23页
一种治疗顽固性高血压的新方法经导管肾神经消融_蒋雄京.ppt_第5页
第5页 / 共23页
点击查看更多>>
资源描述

《一种治疗顽固性高血压的新方法经导管肾神经消融_蒋雄京.ppt》由会员分享,可在线阅读,更多相关《一种治疗顽固性高血压的新方法经导管肾神经消融_蒋雄京.ppt(23页珍藏版)》请在三一文库上搜索。

1、一种治疗顽固性高血压的新方法:经导管肾神经消融,中国医学科学院阜外心血管病医院 蒋 雄 京,Background Hypertension is a global public health problem of major magnitude An estimated 30-40% of the adult population in the developed world suffers from this condition. Despite numerous safe and effective pharmacological therapies, only50% of patient

2、s achieve blood pressure control to guideline targets Renal sympathetic efferent and afferent nerves, which lie in the wall of the renal artery, have been recognized as seminal in the initiation and maintenance of systemic hypertension,Catheter-based renal sympathetic denervation for resistant hyper

3、tension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275,More information,Total body and renal spillover noradrenaline were attenuated as was sympathetic nerve activity. BP reductions were significant and maintained at 12 months (-24/-11mmhg n=63) and over 2 years (-

4、33/-15mmHg n=17) no evidence of procedure related renal artery stenosis. There was some early evidence of organ protection.,Symplicity HTN-2: Denervation effective for treating resistant hypertension Lancet 2010; Advance online A group of 100 patients who, despite taking three or more antihypertensi

5、ve drugs, had a baseline systolic BP of 160 mm Hg 150 mm Hg for type 2 diabetics were randomly assigned to,This procedure provides a revolutionary, non-drug method for controlling high blood pressure in patients who are unresponsive to multiple antihypertensive drugs,Novel therapeutic targets for hy

6、pertension Ludovit Paulis, Thomas Unger Nature Reviews Cardiology 7, 431-441 (August 2010),Further studies are required to confirm the long-term safety and efficacy of this procedure, particularly the risk of catheter-induced atherosclerotic complications or reinervation, minimally invasive percutaneous ablation of renal nerves has some potential for the treatment of patients with resistant hypertension.,感谢!,

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 其他


经营许可证编号:宁ICP备18001539号-1